Strategy for Aortic Surgery Hemostasis
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT03917862
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 200 participants
- Registry
-
NCT03917862
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Unknown status
Technical summary
Registry record NCT03917862. Randomized; no masking; primary purpose treatment. Start 2018-12-04 (actual); primary completion 2020-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Strategy for Aortic Surgery Hemostasis
- Acronym
- SASH
- Condition
- Ascending Aorta Abnormality
- Condition
- Ascending Aortic Dissection
- Condition
- Ascending Aorta Aneurysm
- Intervention (Combination product)
- TDM-621
- Lead sponsor
- University of Sao Paulo General Hospital
- Collaborator
- 3-D Matrix UK Ltd.
- Collaborator
- InCor Heart Institute
Record details
- Record id
cardio:ct-nct03917862- Content hash
ef0dad00be7849fbe3bb0ad88604954ccdb30ee8afb24cdba816dc9be5bb82dc